Furthermore, we use the synthetic biology component to construct the synthetic tetracycline-controllable shRNA for controlling the expression of HOXD-AS1 artificially and inhibiting the progression of bladder cancer cells. Here, HAGLR is linked to urinary bladder carcinoma.